Therapeutic Asset Ratings
200 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
TRASTUZUMAB
Progesterone-Receptor Positive Breast Cancer
Massachusetts General Hospital
P2
B
(57)
Vinorelbine
PR-Positive Breast Cancer
Massachusetts General Hospital
P2
B
(57)
Icosapent Ethyl
Colon Carcinoma
Massachusetts General Hospital
P3
B
(56)
Pemigatinib
Cancer
Massachusetts General Hospital
P2
CCC
(55)
RDX-013 COMPONENT TENAPANOR
Cystic Fibrosis
Massachusetts General Hospital
P3
CCC
(54)
Infliximab
Melanoma
Massachusetts General Hospital
P2
CCC
(54)
ABATACEPT RECOMBINANT
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital
P1/2
CCC
(54)
Ziftomenib
Acute Myeloid Leukemia With 11q23 Abnormalities
Massachusetts General Hospital
P1/2
CCC
(54)
17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL
Mixed Anxiety And Depressive Disorder
Massachusetts General Hospital
P2
CCC
(53)
17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL
HIV Infectious Disease
Massachusetts General Hospital
P2
CCC
(53)
[68ga]cbp8
Radiation-Induced Disorder
Massachusetts General Hospital
P2
CCC
(53)
[68ga]cbp8
Radiation Pneumonitis
Massachusetts General Hospital
P2
CCC
(53)
7-ISOPROPOXYISOFLAVONE
Mild Cognitive Impairment (MCI)
Massachusetts General Hospital
P2
CCC
(53)
7-ISOPROPOXYISOFLAVONE
Subjective Cognitive Decline (SCD)
Massachusetts General Hospital
P2
CCC
(53)
ag-120
Disease Related To Hematopoietic Stem Cell Transplant
Massachusetts General Hospital
P2
CCC
(53)
Bortezomib
Transplant Ineligible
Massachusetts General Hospital
P2
CCC
(53)
Carboplatin
Disease Of Genetic Or Genomic Mechanism
Massachusetts General Hospital
P2
CCC
(53)
cc-5013
Transplant Ineligible
Massachusetts General Hospital
P2
CCC
(53)
Cyclophosphamide
Metastatic Malignant Neoplasm to Brain
Massachusetts General Hospital
P2
CCC
(53)
Cyclophosphamide
Progressive Brain Metastases
Massachusetts General Hospital
P2
CCC
(53)
Cyclophosphamide
Recurrent Brain Metastases
Massachusetts General Hospital
P2
CCC
(53)
DARATUMUMAB
Transplant Ineligible
Massachusetts General Hospital
P2
CCC
(53)
DEXAMETHASONE
Transplant Ineligible
Massachusetts General Hospital
P2
CCC
(53)
DYNAMOS
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital
P2
CCC
(53)
Elranatamab
Transplant Ineligible
Massachusetts General Hospital
P2
CCC
(53)
Showing 51 to 75 of 200 assets
Previous
Page 3 of 8
Next